Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/U.S. Stem Cell, Inc./ CORRESP

SEC Filing · CORRESP

U.S. Stem Cell, Inc.

USRMOTCEQUITYCurrent

SEC Filing

Filed Jul 27, 2022Accepted Jul 27, 2022, 5:00 AM EDTCIK 1388319Accession 0001185185-22-000856
View company →Permanent SEC source ↗
Share

Company context

Current securities

USRMOTC · EQUITY · Current

Recent company filings

  1. NT 10-Q filingMay 15, 2023
  2. 10-K filingApr 14, 2023
  3. NT 10-K filingMar 31, 2023
  4. 10-Q filingNov 9, 2022
  5. 10-Q filingAug 22, 2022

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗